Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel duck reovirus σC hijacks the mitochondrial COQ6-CoQ10 axis to drive NLRP3-dependent pyroptosis.

PLoS pathogens·2026
Same author

Counterion effect on boundary lubrication of cationic surfactant at mica-water interface.

Journal of colloid and interface science·2026
Same author

Alcohol and high-fat diet aggravate colitis-induced liver injury via glucocorticoid/IL-6-SAA1 axis in mice.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026
Same author

The disinhibited cortex as an attractor: Altered burst initiation reveals focal excitatory-inhibitory imbalance.

Neurobiology of disease·2026
Same author

Corrigendum to "VV-ECMO-supported management of severe ARDS secondary to melioidosis sepsis: A case report and concise review" [IDCases 44 (2026) e02612].

IDCases·2026
Same author

VV-ECMO-supported management of severe ARDS secondary to melioidosis sepsis: A case report and concise review.

IDCases·2026

Related Experiment Video

Updated: Apr 4, 2026

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease
06:55

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease

Published on: November 21, 2024

1.4K

Optogenetic tools for modulating and probing the epileptic network.

Mingrui Zhao1, Rose Alleva1, Hongtao Ma1

  • 1Department of Neurological Surgery, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY 10021, USA.

Epilepsy Research
|September 11, 2015
PubMed
Summary

Optogenetics offers new hope for epilepsy patients with drug-resistant seizures. This technique uses light to precisely control neural activity, showing promise in animal models for future human therapies.

Keywords:
Epilepsy modelOptical imagingOptogeneticPhotostimulation

More Related Videos

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K
Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

20.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease
06:55

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease

Published on: November 21, 2024

1.4K
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K
Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

20.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Biotechnology

Background:

  • Epilepsy affects 1% globally, with over 20% experiencing drug-resistant seizures.
  • Existing antiepileptic drugs often have adverse effects, necessitating novel treatments.
  • Optogenetics presents a potential breakthrough for refractory epilepsy cases.

Purpose of the Study:

  • To review recent advances in optogenetic techniques for epilepsy research.
  • To discuss the potential of optogenetics in understanding and treating epilepsy.
  • To highlight optogenetics as a novel therapeutic approach for refractory epilepsy.

Main Methods:

  • Optogenetics combines optics and genetics to control neural activity with light.
  • Delivery of light-sensitive opsin genes (e.g., channelrhodopsin-2, halorhodopsin) into the brain.
  • Precise control of neuronal excitation/inhibition via targeted light wavelengths.

Main Results:

  • Optogenetic neuromodulation has demonstrated effectiveness in treating seizures in epilepsy animal models.
  • High temporal and spatial resolution in controlling specific neuronal populations.
  • Potential for highly targeted and effective epilepsy interventions.

Conclusions:

  • Optogenetics is a powerful tool for advancing epilepsy research.
  • This technology holds significant promise for developing novel therapies for refractory epilepsy.
  • Future applications may revolutionize the management of epilepsy.